...
首页> 外文期刊>Japanese Journal of Pharmacology >SPECIES AND SEX DIFFERENCES IN THE SUBSTRATE-INDUCED SPECTRAL CHANGE OF P-450 IN RELATION TO THE ACTIVITY OF DRUG OXIDATION IN LIVER MICROSOMES
【24h】

SPECIES AND SEX DIFFERENCES IN THE SUBSTRATE-INDUCED SPECTRAL CHANGE OF P-450 IN RELATION TO THE ACTIVITY OF DRUG OXIDATION IN LIVER MICROSOMES

机译:基质诱导的P-450光谱变化的物种和性别差异与肝微粒体中药物氧化的活性有关

获取原文

摘要

References(17) Cited-By(8) A number of foreign compounds of high lipid-solubility are oxidatively metabolized to more water soluble compounds by liver microsomal hydroxylase system, called drugmetabolizing enzymes, in the presence of NADPH and oxygen (1, 2). There are marked species differences among various animals in the activity of drugmetabolizing enzymes, and these species differences are assumed to be responsible factors for the species differences in the effect and toxicity of a variety of drugs (2-5). Recent studies have established that a hemoprotein called P-450 (6) is involved in the monooxygenase reactions in liver microsomes as the oxygen-activating component (7-9). More recently, Imai and Sato (10), and Schenkman et al. (11) have reported that a number of drugs, substrates of hepatic microsomal monooxygenases, react with the microsomal cytochrome to give two characteristic types of spectral change. These results have suggested that the spectral changes observed are indicative of substrate interaction for enzymic hydroxylation (11) and that the magnitude of the substrate binding with cytochrome P-450 is one of important factors for the rate of the over-all hydroxylation of drugs by liver microsomes. It was therefore of interest to investigate whether the magnitude of the substrate binding with P-450 is related to the activity of hydroxylations of drugs by liver microsomes of various species of animals. In the present communication, the magnitude of the substrate binding with P-450 has been investigated in both sexes of rats, mice and rabbits.
机译:参考文献(17)By-By(8)在NADPH和氧气存在下,许多肝溶解性高的外来化合物被肝脏微粒体羟化酶系统氧化代谢为更多的水溶性化合物,称为药物代谢酶(1,2) 。在各种动物之间,药物代谢酶的活性存在明显的物种差异,这些物种差异被认为是造成各种药物作用和毒性的物种差异的重要因素(2-5)。最近的研究已经确定,称为P-450的血红蛋白(6)作为氧激活成分(7-9)参与肝微粒体的单加氧酶反应。最近,Imai和Sato(10),以及Schenkman等人。 (11)报告说,许多药物是肝微粒体单加氧酶的底物,会与微粒体细胞色素发生反应,从而产生两种特征性的光谱变化。这些结果表明,观察到的光谱变化指示了酶促羟基化作用的底物相互作用(11),并且底物与细胞色素P-450结合的程度是影响药物整体羟基化速率的重要因素之一。肝微粒体。因此,有兴趣研究与P-450结合的底物的量是否与各种动物的肝微粒体对药物的羟基化活性有关。在本通讯中,已经在大鼠,小鼠和兔子的两性中研究了与P-450结合的底物的大小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号